Paper15389727
QT prolongation through hERG K(+) channel blockade: current knowledge and strategies for the early prediction during drug development.
Recanatini M and 4 others. Med Res Rev, 2005. Cited by 231 papers, by iCite.
Cite this record
ConductScience Library. QT prolongation through hERG K(+) channel blockade: current knowledge and strategies for the early prediction during drug development. Papers, record 15389727. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/15389727
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- QT prolongation through hERG K(+) channel blockade: current knowledge and strategies for the early prediction during drug development.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Long QT Syndrome | Major topic |
| Potassium Channels, Voltage-Gated | Major topic |
| Animals | |
| Cation Transport Proteins | |
| Electrocardiography | |
| Ether-A-Go-Go Potassium Channels | |
| Humans | |
| Inhibitory Concentration 50 | |
| Models, Biological | |
| Models, Chemical | |
| Potassium | |
| Potassium Channels | |
| Protein Structure, Secondary | |
| Structure-Activity Relationship | |
| Time Factors | |
| Torsades de Pointes |
Source PubMed
Cited by85
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 231 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42794903 | Longitudinal Changes in QTc Interval in Cancer Patients After the Initiation of Systemic Therapy: Analysis of the ONCOECHO Study Cohort. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42794903 | PubMed |
| 42641004 | Synthesis of 4-Hydroxyacetophenone-Derived Bis-Schiff Bases as Potent Cholinesterase Inhibitors: In Vitro Evaluation, Molecular Docking, DFT, and ADMET Analysis. | Chem Biodivers | 2026 | https://conductscience.org/library/papers/42641004 | PubMed |
| 42369237 | Neuronal safety of Kv11.1 blockers: Patch-clamp and in vitro evaluation with physiologically based pharmacokinetic (PBPK) modeling. | Toxicol Rep | 2026 | https://conductscience.org/library/papers/42369237 | PubMed |
| 42105200 | Designing the Next Generation of Antibiotics: Structure, SAR, and Strategy in Medicinal Chemistry (2000-2025). | Med Res Rev | 2026 | https://conductscience.org/library/papers/42105200 | PubMed |
| 41915186 | In-silico toxicity study of tryptamine, psilocin, psilocybin, N,N-dimethyltryptamine, 5'-methoxy-N,N-dimethyltryptamine and O-acetylpsilocin. | Arch Toxicol | 2026 | https://conductscience.org/library/papers/41915186 | PubMed |
| 41871133 | Multitarget docking and molecular enumeration reveal DdpMPyPEPhU as a potent modulator of cell cycle, glucocorticoid, and estrogen signalling in breast cancer. | PLoS One | 2026 | https://conductscience.org/library/papers/41871133 | PubMed |
| 41413149 | In vitro and in silico evaluation of flavonoids from Erythrina crista-galli with cytotoxic potential against MCF-7 breast cancer cell. | Sci Rep | 2025 | https://conductscience.org/library/papers/41413149 | PubMed |
| 41361125 | Qualitative and quantitative in silico toxicity profiling of "angel dust": phencyclidine (PCP) analogues as new psychoactive substances (3-HO-PCP, 3-MeO-PCP, 4-MeO-PCP, 3-HO-PCE, 3-MeO-PCE, 4-MeO-PCE). | Arch Toxicol | 2026 | https://conductscience.org/library/papers/41361125 | PubMed |
| 41208201 | Drug-Induced QT Prolongation: Associations Between Risk Classifications in a Swedish Clinical Decision Support System and Clinical Outcomes. | Clin Pharmacol Ther | 2026 | https://conductscience.org/library/papers/41208201 | PubMed |
| 41110013 | Toxicity of fentanyl (CAS: 437-38-7) and valerylfentanyl (CAS: 122882-90-0): the first integrative in silico toxicology study with clinical and forensic implications. | Arch Toxicol | 2026 | https://conductscience.org/library/papers/41110013 | PubMed |
| 40979544 | Predicting cardiotoxicity in drug development: A deep learning approach. | J Pharm Anal | 2025 | https://conductscience.org/library/papers/40979544 | PubMed |
| 39937319 | Sigma-1 Receptor Specific Biological Functions, Protective Role, and Therapeutic Potential in Cardiovascular Diseases. | Cardiovasc Toxicol | 2025 | https://conductscience.org/library/papers/39937319 | PubMed |
| 39875959 | hERGAT: predicting hERG blockers using graph attention mechanism through atom- and molecule-level interaction analyses. | J Cheminform | 2025 | https://conductscience.org/library/papers/39875959 | PubMed |
| 39716240 | AttenhERG: a reliable and interpretable graph neural network framework for predicting hERG channel blockers. | J Cheminform | 2024 | https://conductscience.org/library/papers/39716240 | PubMed |
| 39466134 | Proton pump inhibitors and cardiovascular risk: a critical review. | Future Cardiol | 2024 | https://conductscience.org/library/papers/39466134 | PubMed |
| 39219930 | Long QT Syndrome With Drugs Used in the Management of Arrhythmias: A Systematic Review. | Cureus | 2024 | https://conductscience.org/library/papers/39219930 | PubMed |
| 38892053 | Toxicity of the New Psychoactive Substance (NPS) Clephedrone (4-Chloromethcathinone, 4-CMC): Prediction of Toxicity Using In Silico Methods for Clinical and Forensic Purposes. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38892053 | PubMed |
| 38057999 | Review of machine learning and deep learning models for toxicity prediction. | Exp Biol Med (Maywood) | 2023 | https://conductscience.org/library/papers/38057999 | PubMed |
| 37969740 | Carbazole and tetrahydro-carboline derivatives as dopamine D3 receptor antagonists with the multiple antipsychotic-like properties. | Acta Pharm Sin B | 2023 | https://conductscience.org/library/papers/37969740 | PubMed |
| 37934066 | Contractility measurements for cardiotoxicity screening with ventricular myocardial slices of pigs. | Cardiovasc Res | 2023 | https://conductscience.org/library/papers/37934066 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ERG | 2078 | PubTator's text mining | https://conductscience.org/library/genes/2078 | NCBI Gene |
| KCNH2 | 3757 | PubTator's text mining | https://conductscience.org/library/genes/3757 | NCBI Gene |
| KCNH6 | 81033 | PubTator's text mining | https://conductscience.org/library/genes/81033 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/15389727
GET https://conductscience.org/api/papers/v1/15389727/cited_by?page=2